Showing results (411-420 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|August 24, 2006
Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinibMarcus Wiedmann, Jürgen Feisthammel, Thilo Blüthner, et al.Anti-Cancer Drugs|August 1, 2009
Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysisChi Young ParkAnti-Cancer Drugs|May 13, 2009
Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literatureEdward James, Maeve G Waldron-Lynch, Muhammad Wasif SaifAnti-Cancer Drugs|March 6, 2009
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patientsGiuseppe Di Lorenzo, Giacomo Cartenì, Riccardo Autorino, et al.Anti-Cancer Drugs|June 4, 2009
Relationship between structure and antiproliferative, proapoptotic, and differentiation effects of flavonoids on chronic myeloid leukemia cellsTanya V Ramanouskaya, Victoria V Smolnykova, Vasily V GrinevAnti-Cancer Drugs|June 4, 2009
Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in ratsSang-Chul Shin, Jun-Shik ChoiAnti-Cancer Drugs|June 4, 2009
Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes beta-catenin cellular localizationNathália G Amado, Débora M Cerqueira, Fabio S Menezes, et al.Anti-Cancer Drugs|March 17, 2009
Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trialGeng Tian, Jiliang Liu, Jie Sui Ruming Zhou, et al.Anti-Cancer Drugs|March 17, 2009
Normal-like breast cells, but not breast cancer cells, recovered from treatment with N',N''-diethylnorspermineLouise Myhre, Kersti Alm, Maria Johansson, et al.Anti-Cancer Drugs|December 10, 2008
Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054James W GrowcottPageof 464